X-Vax Technology Inc, a US-based biotechnology company developing vaccines, announced on Wednesday that it named Varsha K Jain, MD as its new chief clinical development officer.

In the new role, Dr Jain will manage strategy and implementation of the firm's clinical development plan, including preparing for a Phase one clinical study of the company's lead herpes candidate vaccine delta gD-2.

Dr Jain has served as senior program officer, Vaccine Development and Surveillance at the Bill and Melinda Gates Foundation. She has managed influenza, herpes and Lyme disease vaccine programs in Global Vaccine Discovery and Development at GlaxoSmithKline.